IAXTX
Price
$8.52
Change
-$0.00 (-0.00%)
Updated
Apr 22, 6:59 PM EST
PAMCX
Price
$95.87
Change
-$0.00 (-0.00%)
Updated
Apr 22, 6:59 PM EST
Ad is loading...

Compare predictions IAXTX vs PAMCX

Header iconIAXTX vs PAMCX Comparison
Open Charts IAXTX vs PAMCXBanner chart's image
VY® T. Rowe Price Divers Mid Cap Gr S2
Price$8.52
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth Adv
Price$95.87
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
IAXTX vs PAMCX Comparison Chart

Loading...

VS
IAXTX vs. PAMCX commentary
Apr 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IAXTX is a Hold and PAMCX is a StrongSell.

FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 29.6B vs. IAXTX (1.03B). IAXTX (0.00) and PAMCX (0.00) have matching dividends . IAXTX was incepted earlier than PAMCX: IAXTX (15 years) vs PAMCX (24 years). IAXTX is a more actively managed with annual turnover of: 45.00 vs. PAMCX (21.70). IAXTX has a lower initial minimum investment than PAMCX: IAXTX (0) vs PAMCX (2500). IAXTX annual gain was more profitable for investors over the last year : 15.60 vs. PAMCX (6.46). PAMCX return over 5 years is better than : 19.39 vs. IAXTX (1.59).
IAXTXPAMCXIAXTX / PAMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years24 years-
Gain YTD3.7760.905417%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.03B29.6B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year15.606.46241%
Returns for 3 years-28.23-18.85150%
Returns for 5 years1.5919.398%
Returns for 10 years78.72101.7677%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDSB2.990.35
+13.04%
PDS Biotechnology Corp
ALV117.282.45
+2.13%
Autoliv
GERN3.730.04
+1.08%
Geron Corp
ATXS9.800.05
+0.51%
Astria Therapeutics
ZVSA0.57-0.01
-1.91%
ZyVersa Therapeutics